NICE To Adjust Drug Appraisal Standards So Terminally Ill Patients Can Access More Therapies
This article was originally published in The Pink Sheet Daily
Executive Summary
Proposed cost-effectiveness criteria allow medicines in U.K. to be judged on ability to substantially extend life.